INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021
- 29 June 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8444), 1501
- https://doi.org/10.1016/s0140-6736(85)92269-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Synthesis of PAF-acether and blood volume changes in gram-negative sepsisImmunopharmacology, 1985
- PLATELETS AND ASTHMAThe Lancet, 1985
- PLATELETS IN ASTHMAThe Lancet, 1984
- THE PLATELET IN ASTHMAThe Lancet, 1984
- The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotrieneBritish Journal of Pharmacology, 1984
- Acute effects of intratracheal administration of platelet-activating factor in baboonsJournal of Applied Physiology, 1983
- Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pigEuropean Journal of Pharmacology, 1982
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981